Insights

Large-scale bioprocess demand Sartorius’s broad bioprocess portfolio for single-use solutions indicates strong opportunities in manufacturing biologics, vaccines, and cell and gene therapies, suggesting sales potential in both existing production lines and expansion projects.

Global footprint leverage With over 60 production and sales sites worldwide and 14,000+ employees from 110+ nations, there are ample channels for regionalized sales campaigns, localized support packages, and rapid deployment of instrumentation and consumables.

Integrated life sciences stack Combining laboratory instruments, consumables, and bioprocess single-use solutions positions Sartorius to cross-sell end-to-end solutions across discovery, QC, and manufacturing, increasing average deal size and customer lock-in.

Strong financial runway Revenue in the billions and substantial funding indicate capacity for major instrument deployments, expansions, and long-cycle contracts, enabling longer-term sales engagements and multi-year procurement partnerships.

Expansion and acquisitions Regular portfolio expansion through acquisitions shows openness to integrating complementary technologies, creating opportunities for partnership discussions around technology upgrades, migration projects, and bundled solution offerings.

Similar companies to Sartorius

Sartorius Tech Stack

Sartorius uses 8 technology products and services including Hotjar, Matomo, AutoCAD, and more. Explore Sartorius's tech stack below.

Sartorius's Email Address Formats

Sartorius uses at least 8 email formats:
Sartorius Email FormatsExamplePercentage
First.Last@sartorius.comJohn.Doe@sartorius.com
96%
LastF@sartorius.comDoeJ@sartorius.com
2%
Last.First@sartorius.comDoe.John@sartorius.com
1%
First.Middle@sartorius.comJohn.Michael@sartorius.com
1%
First.Last@sartorius-stedim.comJohn.Doe@sartorius-stedim.com
88%
Last@sartorius-stedim.comDoe@sartorius-stedim.com
10%
Last.First@sartorius-stedim.comDoe.John@sartorius-stedim.com
1%
First.Middle@sartorius-stedim.comJohn.Michael@sartorius-stedim.com
1%

Frequently Asked Questions

What is Sartorius's phone number?

Minus sign iconPlus sign icon
You can contact Sartorius's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sartorius's stock symbol?

Minus sign iconPlus sign icon
Sartorius is a publicly traded company; the company's stock symbol is 0NIQ.L.

What is Sartorius's official website and social media links?

Minus sign iconPlus sign icon
Sartorius's official website is sartorius.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Sartorius generate?

Minus sign iconPlus sign icon
As of October 2026, Sartorius's annual revenue is estimated to be $1B - $10B.

What is Sartorius's SIC code and NAICS code?

Minus sign iconPlus sign icon
Sartorius's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sartorius have currently?

Minus sign iconPlus sign icon
As of October 2026, Sartorius has approximately 10K employees across 6 continents, including Europe, North America and Asia. Key team members include Ceo | Sartorius Stedim Biotech S.A: R. F., Ceo: R. C. and Ceo: D. N. Explore Sartorius's employee directory with LeadIQ.

What industry does Sartorius belong to?

Minus sign iconPlus sign icon
Sartorius operates in the Biotechnology Research industry.

What technology does Sartorius use?

Minus sign iconPlus sign icon
Sartorius's tech stack includes Hotjar, Matomo, AutoCAD, Shopify, Google Cloud, Hootsuite, Wistia and Screaming Frog SEO Spider.

What is Sartorius's email format?

Minus sign iconPlus sign icon
Sartorius's email format typically follows the pattern of First.Last@sartorius.com. Find more Sartorius email formats with LeadIQ.

How much funding has Sartorius raised to date?

Minus sign iconPlus sign icon
As of October 2026, Sartorius has raised $3.8B in funding. The last funding round occurred on May 06, 2026 for $3.2B.

When was Sartorius founded?

Minus sign iconPlus sign icon
Sartorius was founded in 1870.
Sartorius logo

Sartorius

Biotechnology ResearchLower Saxony, Germany10001+ Employees

Sartorius is a biotechnology research company headquartered in Göttingen, Germany, with an international presence in biopharma research and manufacturing. It serves laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. Its product portfolio includes laboratory instruments and consumables for these laboratories, and a broad bioprocess offering focused on single-use solutions to enable the manufacture of biotech medicines, vaccines, and cell and gene therapies. The company maintains a global footprint with more than 60 production and sales sites and a workforce of over 14,000 employees from more than 110 nations. Sartorius regularly expands its portfolio through acquisitions of complementary technologies.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
0NIQ.L
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1870
Employees
10001+

Section iconFunding & Financials

  • $3.8B

    Sartorius has raised a total of $3.8B of funding over 2 rounds. Their latest funding round was raised on May 06, 2026 in the amount of $3.2B as a Post IPO Debt.

  • $1B - $10B

    Sartorius's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.